Reports
Reports
Sale
The global human embryonic stem cell market reached a value of about USD 0.94 billion in 2023. The industry is further expected to grow at a CAGR of about 10.6% in the forecast period of 2024-2032 to reach a value of around USD 2.30 billion by 2032.
Human Embryonic Stem Cell Market Size
Human Embryonic Stem Cell Companies
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Human Embryonic Stem Cell Market Analysis
8.1 Key Industry Highlights
8.2 Global Human Embryonic Stem Cell Historical Market (2017-2023)
8.3 Global Human Embryonic Stem Cell Market Forecast (2024-2032)
8.4 Global Human Embryonic Stem Cell Market by Application
8.4.1 Regenerative Medicine
8.4.1.1 Historical Trend (2017-2023)
8.4.1.2 Forecast Trend (2024-2032)
8.4.2 Stem Cell Biology Research
8.4.2.1 Historical Trend (2017-2023)
8.4.2.2 Forecast Trend (2024-2032)
8.4.3 Tissue Engineering
8.4.3.1 Historical Trend (2017-2023)
8.4.3.2 Forecast Trend (2024-2032)
8.4.4 Toxicology Testing
8.4.4.1 Historical Trend (2017-2023)
8.4.4.2 Forecast Trend (2024-2032)
8.5 Global Human Embryonic Stem Cell Market by Region
8.5.1 North America
8.5.1.1 Historical Trend (2017-2023)
8.5.1.2 Forecast Trend (2024-2032)
8.5.2 Europe
8.5.2.1 Historical Trend (2017-2023)
8.5.2.2 Forecast Trend (2024-2032)
8.5.3 Asia Pacific
8.5.3.1 Historical Trend (2017-2023)
8.5.3.2 Forecast Trend (2024-2032)
8.5.4 Latin America
8.5.4.1 Historical Trend (2017-2023)
8.5.4.2 Forecast Trend (2024-2032)
8.5.5 Middle East and Africa
8.5.5.1 Historical Trend (2017-2023)
8.5.5.2 Forecast Trend (2024-2032)
9 North America Human Embryonic Stem Cell Market Analysis
9.1 United States of America
9.1.1 Historical Trend (2017-2023)
9.1.2 Forecast Trend (2024-2032)
9.2 Canada
9.2.1 Historical Trend (2017-2023)
9.2.2 Forecast Trend (2024-2032)
10 Europe Human Embryonic Stem Cell Market Analysis
10.1 United Kingdom
10.1.1 Historical Trend (2017-2023)
10.1.2 Forecast Trend (2024-2032)
10.2 Germany
10.2.1 Historical Trend (2017-2023)
10.2.2 Forecast Trend (2024-2032)
10.3 France
10.3.1 Historical Trend (2017-2023)
10.3.2 Forecast Trend (2024-2032)
10.4 Italy
10.4.1 Historical Trend (2017-2023)
10.4.2 Forecast Trend (2024-2032)
10.5 Others
11 Asia Pacific Human Embryonic Stem Cell Market Analysis
11.1 China
11.1.1 Historical Trend (2017-2023)
11.1.2 Forecast Trend (2024-2032)
11.2 Japan
11.2.1 Historical Trend (2017-2023)
11.2.2 Forecast Trend (2024-2032)
11.3 India
11.3.1 Historical Trend (2017-2023)
11.3.2 Forecast Trend (2024-2032)
11.4 ASEAN
11.4.1 Historical Trend (2017-2023)
11.4.2 Forecast Trend (2024-2032)
11.5 Australia
11.5.1 Historical Trend (2017-2023)
11.5.2 Forecast Trend (2024-2032)
11.6 Others
12 Latin America Human Embryonic Stem Cell Market Analysis
12.1 Brazil
12.1.1 Historical Trend (2017-2023)
12.1.2 Forecast Trend (2024-2032)
12.2 Argentina
12.2.1 Historical Trend (2017-2023)
12.2.2 Forecast Trend (2024-2032)
12.3 Mexico
12.3.1 Historical Trend (2017-2023)
12.3.2 Forecast Trend (2024-2032)
12.4 Others
13 Middle East and Africa Human Embryonic Stem Cell Market Analysis
13.1 Saudi Arabia
13.1.1 Historical Trend (2017-2023)
13.1.2 Forecast Trend (2024-2032)
13.2 United Arab Emirates
13.2.1 Historical Trend (2017-2023)
13.2.2 Forecast Trend (2024-2032)
13.3 Nigeria
13.3.1 Historical Trend (2017-2023)
13.3.2 Forecast Trend (2024-2032)
13.4 South Africa
13.4.1 Historical Trend (2017-2023)
13.4.2 Forecast Trend (2024-2032)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Value Chain Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Company Profiles
16.2.1 Astellas Pharma Inc
16.2.1.1 Company Overview
16.2.1.2 Product Portfolio
16.2.1.3 Demographic Reach and Achievements
16.2.1.4 Certifications
16.2.2 Stemcell Technologies Inc.
16.2.2.1 Company Overview
16.2.2.2 Product Portfolio
16.2.2.3 Demographic Reach and Achievements
16.2.2.4 Certifications
16.2.3 Biotime, INC
16.2.3.1 Company Overview
16.2.3.2 Product Portfolio
16.2.3.3 Demographic Reach and Achievements
16.2.3.4 Certifications
16.2.4 Thermo Fisher Scientific, Inc.
16.2.4.1 Company Overview
16.2.4.2 Product Portfolio
16.2.4.3 Demographic Reach and Achievements
16.2.4.4 Certifications
16.2.5 Others
17 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Human Embryonic Stem Cell Market: Key Industry Highlights, 2017 and 2032
2. Global Human Embryonic Stem Cell Historical Market: Breakup by Application (USD Billion), 2017-2023
3. Global Human Embryonic Stem Cell Market Forecast: Breakup by Application (USD Billion), 2024-2032
4. Global Human Embryonic Stem Cell Historical Market: Breakup by Region (USD Billion), 2017-2023
5. Global Human Embryonic Stem Cell Market Forecast: Breakup by Region (USD Billion), 2024-2032
6. North America Human Embryonic Stem Cell Historical Market: Breakup by Country (USD Billion), 2017-2023
7. North America Human Embryonic Stem Cell Market Forecast: Breakup by Country (USD Billion), 2024-2032
8. Europe Human Embryonic Stem Cell Historical Market: Breakup by Country (USD Billion), 2017-2023
9. Europe Human Embryonic Stem Cell Market Forecast: Breakup by Country (USD Billion), 2024-2032
10. Asia Pacific Human Embryonic Stem Cell Historical Market: Breakup by Country (USD Billion), 2017-2023
11. Asia Pacific Human Embryonic Stem Cell Market Forecast: Breakup by Country (USD Billion), 2024-2032
12. Latin America Human Embryonic Stem Cell Historical Market: Breakup by Country (USD Billion), 2017-2023
13. Latin America Human Embryonic Stem Cell Market Forecast: Breakup by Country (USD Billion), 2024-2032
14. Middle East and Africa Human Embryonic Stem Cell Historical Market: Breakup by Country (USD Billion), 2017-2023
15. Middle East and Africa Human Embryonic Stem Cell Market Forecast: Breakup by Country (USD Billion), 2024-2032
16. Global Human Embryonic Stem Cell Market Structure
In 2023, the market attained a value of approximately USD 0.94 billion.
The market is projected to grow at a CAGR of 10.6% between 2024 and 2032.
The market is estimated to witness a healthy growth in the forecast period of 2024-2032 to reach about USD 2.30 billion by 2032.
The major drivers of the market include the rapid progress in laboratory technologies, investments by various governments, rising prevalence of cardiac and malignant diseases, and the establishment of various disease models.
The rising research and development activities, advancements in stem culturing and derivation, and rapid advancements in technologies are the key trends propelling the growth of the market.
The major regions in the market are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The leading applications in the market are regenerative medicine, stem cell biology research, tissue engineering, and toxicology testing.
The key players in the global human embryonic stem cell market are Astellas Pharma Inc, Stemcell Technologies Inc., Biotime, INC, and Thermo Fisher Scientific, Inc., among others.
The global human embryonic stem cell market attained a value of nearly USD 0.94 billion in 2023, driven by the rising research and development activities and advancement in technologies. Aided by the development of laboratory technologies, the market is expected to witness a further growth in the forecast period of 2024-2032, growing at a CAGR of 10.6%. The market is projected to reach USD 2.30 billion by 2032.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. The major application segments in the industry are regenerative medicine, stem cell biology research, tissue engineering, and toxicology testing. The major regional markets for human embryonic stem cell are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market are Astellas Pharma Inc, Stemcell Technologies Inc., Biotime, INC, and Thermo Fisher Scientific, Inc., among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Datasheet
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.